Sign In
Buy XRAY
$13.37
-0.370 (-2.69%)
At Close: Jul 31, 2026
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
12:10am, Friday, 25'th Feb 2022 Zacks Investment Research
Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
12:45pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
CHARLOTTE, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that Dr. Dorothea Wenzel has been appointed to its Board of Directors (
DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?
12:06pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.
DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?
08:29am, Tuesday, 22'nd Feb 2022
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.
Dentsply International (XRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
08:01pm, Monday, 21'st Feb 2022 Zacks Investment Research
Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN Healthcare (AMN) to Report Q4 Earnings: What's in Store?
03:09pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
AMN Healthcare's (AMN) fourth-quarter results are likely to reflect solid demand in some of the areas of its business.
OPKO Health (OPK) to Post Q4 Earnings: What's in the Cards?
04:53pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
OPKO Health's (OPK) fourth-quarter results are likely to reflect strength in Rayaldee.
What's in Store for West Pharmaceutical's (WST) Q4 Earnings?
04:52pm, Monday, 14'th Feb 2022 Zacks Investment Research
West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.
Baxter (BAX) to Report Q4 Earnings: What's in the Offing?
04:35pm, Monday, 14'th Feb 2022 Zacks Investment Research
Baxter's (BAX) fourth-quarter results are likely to reflect growth in its Acute Therapies business.
Byte Proud to Recognize TODEC Legal Centers Community Efforts, Starts 2022 With $5,000 Donation
08:00pm, Friday, 11'th Feb 2022 Kwhen Finance
Why the Earnings Surprise Streak Could Continue for Dentsply (XRAY)
05:10pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
03:51pm, Thursday, 10'th Feb 2022 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Why the Earnings Surprise Streak Could Continue for Dentsply (XRAY)
01:50pm, Thursday, 10'th Feb 2022
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
12:19pm, Thursday, 10'th Feb 2022
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
3 Medical Products Stocks Poised to Beat This Earnings Season
02:49pm, Monday, 07'th Feb 2022 Zacks Investment Research
The Medical Products companies' Q4 results are likely to reflect base business recovery. Let's see how BAX, HSIC, and XRAY are poised ahead of their earnings releases.
